Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias.

作者: M W Huff , A J Evans , C G Sawyez , B M Wolfe , P J Nestel

DOI: 10.1161/01.ATV.11.2.221

关键词:

摘要: The capacity of human triglyceride-rich lipoproteins to induce cholesterol accumulation in the murine J774 macrophage cell line was investigated with large very low density lipoprotein (VLDL, Sf 60-400) obtained from subjects type III, IV, and V hyperlipoproteinemias. After incubation for 24 hours, VLDLs IV were similar their ability raise cellular deposition threefold fourfold triglyceride 16-fold. increase entirely due dramatic ester, less than 1 greater 50 micrograms/mg protein. Total fivefold observed VLDL or (LDL) normal subjects. Cholesterol esterification (acyl coenzyme A: acyltransferase [ACAT] activity) paralleled rate these cells. Treating macrophages ACAT inhibitor 58035, which is known downregulate LDL receptor cells, diminished by 40% 23% LDL. Since hypertriglyceridemic carries excess apoprotein (apo) E molecules, we role abnormal apo E. An anti-apo monoclonal antibody, block binding receptor, blocked VLDL-induced ester approximately 70%. In contrast subjects, III (homozygous E2) when incubated (which do not secrete E) caused only a modest 1.5-2-fold cholesterol. Pre-beta- beta-migrating subfractions equally ineffective causing accumulation. By contrast, beta-VLDL cholesterol-fed rabbits sevenfold eightfold content. These results indicate that can cause substantial enhanced lower presence antibodies demonstrates importance functional this process.

参考文章(64)
E. J. Bartucci, R. W. Wissler, T. Schaffner, S. Glagov, K. Taylor, J. H. Beeson, K. Fischer-Dzoga, Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. American Journal of Pathology. ,vol. 100, pp. 57- 80 ,(1980)
Mahley Rw, Development of accelerated atherosclerosis. Concepts derived from cell biology and animal model studies. Archives of Pathology & Laboratory Medicine. ,vol. 107, pp. 393- 399 ,(1983)
Karl H. Weisgraber, Robert W. Mahley, Characterization of apolipoprotein E-containing lipoproteins Methods in Enzymology. ,vol. 129, pp. 145- 166 ,(1986) , 10.1016/0076-6879(86)29067-9
T L Innerarity, K H Weisgraber, K S Arnold, S C Rall, R W Mahley, Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. Journal of Biological Chemistry. ,vol. 259, pp. 7261- 7267 ,(1984) , 10.1016/S0021-9258(17)39866-6
Ross W. Milne, Yves L. Marcel, Monoclonal antibodies against human low density lipoprotein FEBS Letters. ,vol. 146, pp. 97- 100 ,(1982) , 10.1016/0014-5793(82)80712-6
W A Bradley, S L Hwang, J B Karlin, A H Lin, S C Prasad, A M Gotto, S H Gianturco, Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. Journal of Biological Chemistry. ,vol. 259, pp. 14728- 14735 ,(1984) , 10.1016/S0021-9258(17)42663-9
C Koo, M E Wernette-Hammond, T L Innerarity, Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor. Journal of Biological Chemistry. ,vol. 261, pp. 11194- 11201 ,(1986) , 10.1016/S0021-9258(18)67367-3